From: A phase I study of combination vaccine treatment of five therapeutic epitope-peptides for metastatic colorectal cancer; safety, immunological response, and clinical outcome
Dose of peptide (mg)
Patients
R
T
K
R1
R2
Total
Average*
n
Within 3 courses of vaccinations
0.5
3
2
0
1
6
2.0
7
2.3
4
5
19
3.2**
3 (cocktail)
21
3.5**